Figure-1 (Figure 1)
Balsalazide Disodium Capsule
Product Images NDC 50268-102
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Balsalazide Disodium (NDC 50268-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label 5026810313 Balsalazide 2017
This is a description of Balsalazide Disodium Capsules, USP, with NDC 50268-102-13. It comes in a unit dose pack of 30 capsules. Each capsule contains 750mg of balsalazide disodium. The usual dosage instructions can be found in the package insert. It is a prescription drug and should be stored at 20° to 25°C (68° to 77°F), with excursions allowed to 15-30°C (59° to 86°F). It is manufactured by AVKARE, Inc. and should be kept out of reach of children.*
Structural-formula (Structural Formula)
Not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
